Key Highlights

  • CME Group's $1.30 quarterly Dividend trades ex-date September 9, 2026, payable September 25, yielding approximately 1.80%.
  • Second-quarter Revenue reached a record $1.7 billion, with adjusted diluted EPS of $2.99, capping the strongest first half in company history.
  • CME operates an annual variable-dividend program on top of the regular payout, having declared $6.15 per share in February 2026 based on 2025 results.
  • Chairman and CEO Terry Duffy will transition to executive chairman in March 2027, with CFO Lynne Fitzpatrick set to become CEO.

CME Group's (NASDAQ:CME) $1.30 quarterly dividend yields approximately 1.80%, a payout backed by the strongest first half in the exchange operator's history. The more consequential story is a Leadership transition announced alongside these results: longtime Chairman and CEO Terry Duffy will step down as CEO in March 2027, handing the role to current CFO Lynne Fitzpatrick, a succession investors will want to weigh against the company's otherwise steady operating momentum.

Dividend Program and Shareholder Returns

CME's board declared a $1.30 per share quarterly dividend on August 6, 2026, payable September 25 to shareholders of record September 9. The company increased its regular quarterly dividend to $1.30 from $1.25 earlier in 2026. Beyond the regular payout, CME operates an annual variable-dividend program tied to prior-year results, having declared $6.15 per share in February 2026 based on 2025 performance, meaning total annual shareholder distributions can run well above the four regular quarterly payments combined.

About the Company

CME Group operates one of the world's largest Derivatives marketplaces, offering futures and Options across interest rates, Equity indexes, foreign exchange, energy, agricultural products, metals and cryptocurrencies through CME, CBOT, NYMEX and COMEX. The company also provides central-counterparty clearing through CME Clearing and electronic trading via BrokerTec and EBS, businesses characterized by high Operating Leverage since incremental electronic transactions carry relatively low marginal cost.

Financial Performance Behind the Payout

CME reported second-quarter revenue of $1.7 billion, with GAAP Operating Income of $1.1 billion, Net Income of $1.0 billion and diluted EPS of $2.88. On an adjusted basis, operating income was $1.2 billion, net income was $1.1 billion and adjusted diluted EPS was $2.99. Market data revenue reached a record $238 million, up 20% year over year, marking 33 consecutive quarters of growth. Management described the first half of 2026 as the strongest in company history across revenue, adjusted operating income, adjusted net income and adjusted EPS.

A Planned Leadership Handoff, Not a Sudden Departure

CME's succession plan gives the market an unusually long runway to assess the transition: Duffy remains CEO until March 2027 before moving to executive chairman, while Fitzpatrick, the sitting CFO, steps into the top role with deep familiarity with the company's finances and strategy. The timing coincides with genuinely strong underlying performance, record H1 revenue and volumes, so the succession does not appear tied to any operational strain. The open question is whether Fitzpatrick's tenure will bring changes to capital-return policy, including the variable dividend program that has become a hallmark of CME's shareholder-return approach.

Outlook

CME's dividend is well supported by exceptionally strong operating Economics and record trading volumes, though the 2027 CEO transition introduces a modest governance variable for investors to monitor over the coming year. Investors should watch average daily volume, open interest growth, market data revenue trends and any early signals of strategic continuity or change as the leadership transition approaches.

Not based on current results. The transition was announced alongside record first-half revenue and trading volumes, suggesting a planned succession rather than a response to any operating weakness.

Likely, though not guaranteed. The program is tied to CME's cash-generation model and has been a consistent feature of Capital returns, but any policy changes under incoming CEO Fitzpatrick have not yet been indicated.

Broad-based Volume growth. Record market data revenue, strong Average Daily Volume and rising open interest across multiple asset classes are the primary contributors, reflecting sustained Demand for risk-management products.